Physician

Albert F Mapp, MD

According to 2025 Medicare claims, Albert Mapp, MD (NPI: 1184689895) practices family practice in the Panama City-Panama City Beach, FL market, with the plurality of this provider's patient population coming from Bay, FL. This provider's primary affiliated billing organization is ALBERT F MAPP JR M D P A (NPI: 1295922086; TIN: 593245567) and primary practice location at 32404-6126.

Mapp's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 365 traditional Medicare patients, billed 9,060 HCPCS/CPT codes, and received $244,328 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 5,090 prescription claims across 247 beneficiaries totaling $321,840 in drug costs, led by Eliquis (Apixaban). DME data shows 228 claims. Open Payments data shows 1 records totaling $17. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $42,655 and ending at $19,433.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	603	4,976	$248,186
2016	1,039	4,954	$279,428
2017	1,037	5,185	$267,278
2018	840	4,786	$223,164
2019	602	5,068	$258,925
2020	371	4,670	$236,050
2021	388	5,427	$303,171
2022	376	5,179	$265,959
2023	382	5,350	$271,211
2024	365	9,060	$244,328

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	184	3,975	$274,061
2016	209	3,826	$342,999
2017	224	3,759	$295,564
2018	235	3,420	$252,262
2019	188	3,084	$212,613
2020	149	3,073	$231,306
2021	179	3,432	$229,233
2022	196	3,797	$233,758
2023	224	4,191	$281,771
2024	247	5,090	$321,840

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	141	624	$34,586
2016	208	656	$24,431
2017	132	449	$12,545
2018	100	359	$9,940
2019	59	331	$9,845
2020	61	345	$13,137
2021	12	147	$10,982
2022	23	180	$17,989
2023	N/R	155	$10,815
2024	N/R	228	$12,806

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	268	268	$125
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	270	880	$87
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	344	1,405	$60
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	209	374	$11
96372	Injection of drug or substance under skin or into muscle	125	496	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	50	3,106	$58,871
Januvia	Sitagliptin Phosphate	41	2,130	$32,170
Trulicity	Dulaglutide	16	672	$22,440
Xarelto	Rivaroxaban	12	1,080	$18,047
Tradjenta	Linagliptin	11	930	$14,828

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	13	$3,487
E0745	Neuromuscular stimulator, electronic shock unit	Y	N/R	33	$2,478
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	31	$2,302
A7032	Cushion for use on nasal mask interface, replacement only, each	N	N/R	16	$1,607
E0601	Continuous positive airway pressure (cpap) device	Y	N/R	26	$799

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$17	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Albert F. Mapp, MD?

Tedicare shows public-source Medicare data for Albert F. Mapp, MD (NPI 1184689895), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Albert F. Mapp, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Albert F. Mapp, MD?

Albert F. Mapp, MD is linked to ALBERT F MAPP JR M D P A (billing NPI 1295922086) in the available physician profile data.

Does Albert F. Mapp, MD have Open Payments data?

Albert F. Mapp, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.